SCHEMBL7898352

SCHEMBL7898352

CCSc1nc(N)nc2c1ncn2CCOC(P)(CC(F)(F)F)CC(F)(F)F

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 5/20 0.47
SLC29A1 Q99808 6/20 0.47
CYP1A2 P05177 6/20 0.45
CYP2C9 P11712 4/20 0.45
HIF1A Q16665 4/20 0.45
CYP3A4 P08684 3/20 0.45
CYP2D6 P10635 3/20 0.45
CDK1 P06493 3/20 0.40
CCNB1 P14635 3/20 0.40
CCNE1 P24864 3/20 0.40
CDK2 P24941 3/20 0.40
ALDH1A1 P00352 1/20 0.40
PHLPP2 Q6ZVD8 1/20 0.40
TP53 P04637 1/20 0.38
TLR9 Q9NR96 2/20 0.34
TLR7 Q9NYK1 2/20 0.34
NSD2 O96028 1/20 0.32
NSD3 Q9BZ95 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7595179 0.84 CYP2C19 (0.49) CYP2C19SLC29A1CYP1A2CYP2C9HIF1A
SCHEMBL7596236 0.84 SLC29A1 (0.39) CYP2C19SLC29A1CYP1A2CYP2C9HIF1A
Hydrochloric Acid SCHEMBL7592338 0.84 CYP2C19 (0.48) CYP2C19SLC29A1CYP1A2CYP2C9HIF1A
SCHEMBL15532061 0.83 SLC29A1 (0.40) CYP2C19SLC29A1CYP1A2CYP2C9HIF1A
SCHEMBL7765668 0.83 SLC29A1 (0.43) CYP2C19SLC29A1CYP1A2CYP2C9HIF1A
SCHEMBL15532145 0.82 SLC29A1 (0.41) CYP2C19SLC29A1CYP1A2CYP2C9HIF1A
SCHEMBL15532188 0.82 SLC29A1 (0.44) CYP2C19SLC29A1CYP1A2CYP2C9HIF1A
SCHEMBL6838428 0.82 NSD3 (0.40) CYP2C19SLC29A1CYP1A2CYP2C9HIF1A
SCHEMBL7765688 0.81 SLC29A1 (0.41) CYP2C19SLC29A1CYP1A2CYP2C9HIF1A
SCHEMBL7593647 0.80 CYP2C19 (0.46) CYP2C19SLC29A1CYP1A2CYP2C9HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6194398-B1 VIRICIDES AGAINST HUMAN IMMUNODEFICIENCY VIRUS, HERPES SIMPLEX VIRUS, HEPATITIS B VIRUS; ANTITUMOR AGENTS; SIDE EFFECT REDUCTION; ORAL ABSORPTION BIOAVAILABILITY; A 2-AMINO-6-HYDROCARBYLTHIO-9-(2-(PHOSPHONOMETHOXY)ETHYL-9H-PURINE MITSUBISHI CHEMICAL CORPORATION (JP) 2001-02-27 US disclosed